Psychiatry & Neurology Doctors in Nevada, MO Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

Dr. Abdul Mateen, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1500 W Ashland St, Nevada, MO 64772 Phone: 417-667-2666

Mohammad A Rasheed, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 320 Mac Blvd, Nevada, MO 64772 Phone: 888-403-1071

Dr. Candice A. Moore, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 815 S Ash St, Nevada, MO 64772 Phone: 417-667-8352

Azmi Ramin Jahan, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1500 W Ashland St, Nevada, MO 64772 Phone: 417-448-5623

Vernon Kent Cooper, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 800 S Ash St, Nevada, MO 64772 Phone: 417-448-3642    Fax: 417-448-3641

News Archive

Three health care organizations implement interconnected EHR system

Three of the largest Front Range health care organizations are taking an unprecedented leap forward in health care reform by improving care for more than a million Coloradans with an interconnected electronic patient record exchange system.

FDA approves Wyeth Pharmaceuticals' Prevnar 13 pneumococcal disease vaccine

The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.

Simple bedside test may identify heart attack risk

The reason behind why patients who are on aspirin still have heart attacks is an important topic in cardiovascular disease.

New screening test detects 20 types of cancer

Researchers from the Dana-Farber Cancer Institute have developed a new blood test that would accurately determine the presence of several types of cancers. The results of their multi-centre clinical trial to prove the effectiveness of their test was presented by the researchers at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, on the 28th of September 2019.

Read more Medical News

› Verified 5 days ago